Apixaban plus P2Y12 inhibitor and no aspirin safest for patients with both AFib and ACS
Patients at high risk for heart attacks, strokes and blood clots who were treated with a novel blood thinner (apixaban) and an antiplatelet drug such as clopidogrel had a significantly lower risk of bleeding and being hospitalized ...
Mar 18, 2019
0
2